Walkner Condon Financial Advisors LLC Merck & Co., Inc. Transaction History
Walkner Condon Financial Advisors LLC
- $529 Million
- Q2 2025
A detailed history of Walkner Condon Financial Advisors LLC transactions in Merck & Co., Inc. stock. As of the latest transaction made, Walkner Condon Financial Advisors LLC holds 3,253 shares of MRK stock, worth $272,991. This represents 0.05% of its overall portfolio holdings.
Number of Shares
3,253
Previous 3,080
5.62%
Holding current value
$272,991
Previous $276,000
6.88%
% of portfolio
0.05%
Previous 0.06%
Shares
14 transactions
Others Institutions Holding MRK
# of Institutions
3,853Shares Held
1.96BCall Options Held
29.2MPut Options Held
30M-
Vanguard Group Inc Valley Forge, PA253MShares$21.2 Billion0.34% of portfolio
-
Black Rock Inc. New York, NY207MShares$17.4 Billion0.59% of portfolio
-
State Street Corp Boston, MA118MShares$9.94 Billion0.36% of portfolio
-
Wellington Management Group LLP Boston, MA76.9MShares$6.45 Billion1.15% of portfolio
-
Geode Capital Management, LLC Boston, MA59MShares$4.95 Billion0.34% of portfolio
About Merck & Co., Inc.
- Ticker MRK
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,533,280,000
- Market Cap $213B
- Description
- Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...